查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1657673

全球筆針市場按類型、長度、應用、購買模式、醫療保健環境和地區分類 - 預測至 2030 年

Pen Needles Market by Type, Length, Setting, Application, Mode of Purchase - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 286 Pages | 商品交期: 最快1-2個工作天內

價格

預計筆式針頭市場規模將從 2024 年的 18.1 億美元成長到 2030 年的 30.8 億美元，預測期內的複合年成長率為 9.2%。

隨著老齡化，人們更容易出現胰島素抗性、胰臟功能下降、高血壓和肥胖等併發症，增加糖尿病的風險。隨著老齡化，身體產生胰島素來調節血糖值的能力會下降，從而增加罹患第 2 型糖尿病的可能性。此外，老年人體力活動減少和生活方式的改變也是導致糖尿病發病率上升的原因之一。隨著老齡化的成長，糖尿病的盛行率不斷上升，這對胰島素注射裝置（尤其是筆式針頭）的需求增加有著簡單而直接的影響。胰島素注射是老年人糖尿病管理的重要組成部分，尤其是患有第 1 型或晚期第 2 型糖尿病的患者。與傳統注射器相比，筆式針頭使用起來簡單、方便且疼痛減輕，特別適合老年人。許多老年人所患的其他疾病包括關節炎，這主要會妨礙使用注射器，導致人們普遍偏好使用筆針的胰島素筆。

研究範圍
調查年份 2022-2030
基準年 2023
預測期 2024-2030
考慮單位 金額（美元）
按細分市場 按類型、長度、用途、購買方式、醫療環境、地區
目標區域 北美、歐洲、亞太地區、中東和非洲、拉丁美洲、海灣合作理事會國家

標準針頭在全球市場上市場佔有率主導地位，因為其與用於胰島素注射和其他注射藥物的大多數筆式注射器具有廣泛的兼容性。這些針頭經過開發，可以適用於多種胰島素筆，適合所有類型的患者。它的簡單性和可負擔性使其廣受歡迎，在人口對成本較為敏感的地區你會發現它的易用性。標準筆針也適合第 1 型和第 2 型糖尿病患者。因此，標準筆針被廣泛用於所有這些情況，並且患者及其醫療保健提供者將其作為首選。

由於電子商務平台提供的優勢和便利，全球筆式針頭市場的線上採購部分預計將在預測期內呈現最高的成長率。例如，該網站提供有競爭力的價格，有時還提供折扣、促銷優惠和捆綁交易，可以讓客戶以更便宜的價格購買筆式針頭。除此之外，網路購物的吸引力比傳統零售店更大，因為更容易比較產品、閱讀客戶評論並獲得全面的產品和尺寸。線上平台的推出也將增加偏遠地區或行動不便的客戶的便利性，因為他們可以在家中收到書寫工具。採用電子商務更方便、更具成本效益，因此網上購物產業必將強勁成長。

本報告研究了全球筆針市場，並根據類型、長度、應用、購買模式、醫療環境、區域趨勢和公司概況對市場進行了詳細的分析。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章 市場概況

  • 介紹
  • 市場動態
  • 產業趨勢
  • 贖回情況
  • 定價分析
  • 價值鏈分析
  • 生態系分析
  • 波特五力分析
  • 供應鏈分析
  • 監管分析
  • 貿易分析
  • 專利分析
  • 主要相關人員和採購標準
  • 案例研究分析
  • 技術分析
  • 2025-2026 年重要會議與活動
  • 鄰近市場分析
  • 人工智慧/生成式人工智慧對注射筆針頭市場的影響
  • 影響客戶業務的趨勢/干擾
  • 未滿足需求分析
  • 投資金籌措場景

第 6 章 筆針市場，依類型

  • 介紹
  • 標準筆針
  • 安全筆針

7. 筆針市場，依長度分類

  • 介紹
  • 8mm
  • 5mm
  • 6mm
  • 4mm
  • 12mm
  • 10mm

第 8 章 筆針市場，依應用

  • 介紹
  • 胰島素治療
  • Glucagon-Like Peptide-1療法
  • 生長激素荷爾蒙療法
  • 骨質疏鬆症
  • 其他

第9章。

  • 介紹
  • 處方箋購買
  • 場外購買
  • 線上購買
  • 其他

第 10 章。

  • 介紹
  • 居家醫療
  • 醫院和診所
  • 其他

第 11 章 筆針市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 澳洲和紐西蘭
    • 印度
    • 韓國
    • 東南亞
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中東和非洲
    • 慢性病增加將推動成長
    • 中東和非洲宏觀經濟展望
  • 海灣合作理事會國家
    • 可支配所得增加推動經濟成長
    • 海灣合作理事會國家的宏觀經濟展望

第12章 競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 2019 至 2023 年收益分析
  • 2023 年市場佔有率分析
  • 公司估值矩陣：主要參與企業，2023 年
  • 公司估值矩陣：Start-Ups/中小企業，2023 年
  • 估值及財務指標
  • 競爭場景
  • 品牌/產品比較
  • 主要企業研發支出

第13章 公司簡介

  • 主要參與企業
    • EMBECTA CORP.
    • NOVO NORDISK A/S
    • B. BRAUN SE
    • YPSOMED
    • TERUMO CORPORATION
    • NIPRO
    • OWEN MUMFORD
    • ARKRAY, INC.
    • ULTIMED, INC.
    • HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.
    • MONTMED
    • HTL-STREFA
    • ALLISON MEDICAL, INC.
    • GLUCORX LIMITED
    • BERPU MEDICAL TECHNOLOGY CO., LTD.
  • 其他公司
    • VAN HEEK MEDICAL
    • SIMPLE DIAGNOSTICS
    • IYON HEALTH MEDICAL
    • LINKS MEDICAL PRODUCTS INC.
    • MHC MEDICAL PRODUCTS, LLC
    • ADVACARE PHARMA
    • ARTSANA SPA
    • PROMISEMED MEDICAL DEVICES, INC.
    • TRIVIDIA HEALTH, INC.
    • VOGT MEDICAL VERTRIEB GMBH

第14章 附錄

Product Code: MD 2851

The pen needles market is projected to reach USD 3.08 Billion by 2030 from USD 1.81 Billion in 2024 at a CAGR of 9.2% during the forecast period. The elderly are susceptible, due to their age, to insulin resistance, a decrease in pancreatic function, and other comorbid conditions, including hypertension and obesity, which raise the risk of developing diabetes. As people age, the body becomes less responsive to insulin's role in regulating blood sugar, hence increasing the chances of developing Type 2 diabetes. In addition, the reduction in physical activity among older adults, coupled with lifestyle changes, contributes to rising trends of the condition. The increasing incidence rate of diabetes with age has simple direct implications concerning the increased desire for insulin administration devices, especially the pen needles. Insulin injections are an essential component of diabetes management among elderly patients, especially patients with Type 1 or advanced Type 2 diabetes. Ease of use, convenience, and reduced pain compared to traditional syringes make the pen needle particularly suitable for older adults. Other conditions most of the elderly suffer from include arthritis, which could primarily hinder them using syringes, hence developing the preference for insulin pens that use pen needles.

Scope of the Report
Years Considered for the Study2022-2030
Base Year2023
Forecast Period2024-2030
Units ConsideredValue (USD)
SegmentsBy Type, Length, Application, Mode of Purchase, Setting and Region
Regions coveredNorth America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries

"The standard pen needles segment is accounted for the largest share of global pen needles market."

The market share of pen needles in the global market is dominated by the standard ones because of their wide compatibility with most of the pen injectors used for insulin administration and other injectable drugs. These needles are developed to be able to fit in a variety of insulin pens, making them available to patients across all demographics.Their simplicity and affordability make them popular, and their ease of use is something that is found in regions whose populations are rather cost-sensitive. Standard pen needles are also apt for Type 1 and Type 2 diabetes patients. Other patients also require injectable medications for some other conditions; hence, standard pen needles find wide usage in all these conditions, making the patients and their healthcare providers retain them as a first choice for their use.

"Online purchase segment will grow at the highest CAGR during the forecast period of the global pen needles market."

The online purchase segment of the global pen needles market is expected to have the highest growth rate during the forecast period due to the benefits and convenience that e-commerce platforms have provided. For instance, the websites provide competitive prices and, sometimes, offer discounts, promotional offers, and bundle deals that can make the purchase of pen needles cheaper for customers. Apart from this, the appeal of online shopping is greater than traditional retail shops due to more ease in product comparison, reading customer reviews, and availability of a comprehensive range of products and sizes. The availability on online platforms also increases the accessibility for customers located at remote locations or those with some mobility issues since they can receive their pen needles at home. E-commerce adoption, with more convenience and cost-effectiveness, ensures that the segment of online purchases is going to grow strongly.

"North America to witness the substantial growth rate during the forecast period."

The pen needles market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC Countries based on the region type. In 2024, the Asia Pacific region is projected to exhibit the highest CAGR during the forecast period. However, North America accounts for the largest market share of the pen needles market in 2024. This is largely because of the health care systems that are advanced to facilitate better access to diabetes care. The U.S. and Canada have a well-developed medical infrastructure, making it easy for patients to reach pen needles for insulin delivery devices. Furthermore, with millions of people suffering from diabetes in these regions, there is high demand for effective, as well as user-friendly, delivery solutions. Pen needles are popular for their convenience, ease of use, and minimal discomfort. It is the preferred way to manage Type 1 and Type 2 diabetes. With extensive healthcare coverage, a high patient awareness level, and a large diabetic population, North America is the most significant market for pen needles.

A breakdown of the primary participants (supply-side) for the pen needles market referred to for this report is provided below:

  • By Company Type: Tier 1-22%, Tier 2-36%, and Tier 3-42%
  • By Designation: C-level-23%, Director Level-28%, and Others-49%
  • By Region: North America-38%, Europe-29%, Asia Pacific-23%, Latin America- 6%, and Middle East and Africa- 1% and GCC Countries- 3%

Prominent players in this market include Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), B. Braun SE (Germany), Owen Mumford (UK), Terumo Corporation (Japan), NIPRO Corporation (Japan), Allison Medical, Inc. (US), AdvaCare Pharma (US), Berpu Medical Technology Co., Ltd. (China), ARKRAY, Inc. (Japan), GlucoRx Limited (UK), HTL-STREFA (Poland), UltiMed, Inc. (US), Hindustan Syringes and Medical Devices (India), Artsana Group (Italy), PromiseMed Medical Devices Inc. (Canada), Montmed, Inc. (Canada), Trividia Health, Inc. (US), VOGT Medical Vertrieb GmbH (Germany), Van Heek Medical (Netherlands), Simple Diagnostics (US), IYON Medical (Turkey), Links Medical Products, Inc. (US), and MHC Medical Products, LLC (US).

Research Coverage:

The market study covers the pen needles market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, length, application, mode of purchase, setting and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of Market Dynamics: Drivers (rising incidence of chronic diseases, favorable reimbursements in certain countries, and decreasing prices of insulin formulations) restraints (rising pet care costs, poor reimbursement scenario in emerging countries, and needle anxiety) opportunities (growing preference for biosimilar drugs, emerging economies to offer high-growth potential, and rising healthcare expenditure on diabetes), and challenges (implementation of regulations for safety pen needles, reuse of pen needles, and misuse of injection pens)
  • Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the pen needles market.
  • Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, end-user, and region.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the pen needles market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the pen needles market like Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), B. Braun SE (Germany), and Terumo Corporation (Japan).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
    • 1.2.2 MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED
    • 1.2.4 CURRENCY CONSIDERED
  • 1.3 LIMITATIONS
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 METHODOLOGY-RELATED LIMITATIONS
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 PEN NEEDLES MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH AND COUNTRY (2024)
  • 4.3 GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 REGIONAL MIX

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising incidence of chronic diseases
      • 5.2.1.2 Favorable reimbursements in certain countries
      • 5.2.1.3 Growing adoption of self-administration
      • 5.2.1.4 Decreasing prices of insulin formulations
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Alternative methods of drug delivery
      • 5.2.2.2 Poor reimbursement scenario in emerging markets
      • 5.2.2.3 Needle anxiety
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing preference for biosimilar drugs
      • 5.2.3.2 Emerging economies to offer high-growth potential
      • 5.2.3.3 Rising healthcare expenditure on diabetes
      • 5.2.3.4 Implementation of regulations for safety pen needles
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Reuse of pen needles
      • 5.2.4.2 Misuse of injection pens
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 GROWING PREFERENCE FOR SAFETY-ENGINEERED PEN NEEDLES
    • 5.3.2 RISING ADOPTION OF SHORTER AND ULTRA-THIN NEEDLES
  • 5.4 REIMBURSEMENT SCENARIO
  • 5.5 PRICING ANALYSIS
    • 5.5.1 INDICATIVE SELLING PRICE OF PEN NEEDLES, BY KEY PLAYER, 2024
    • 5.5.2 AVERAGE SELLING PRICE TREND OF STANDARD PEN NEEDLES, BY REGION, 2022-2024
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.8.2 BARGAINING POWER OF SUPPLIERS
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 THREAT OF SUBSTITUTES
    • 5.8.5 THREAT OF NEW ENTRANTS
  • 5.9 SUPPLY CHAIN ANALYSIS
  • 5.10 REGULATORY ANALYSIS
    • 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.10.2 REGULATORY FRAMEWORK
      • 5.10.2.1 North America
        • 5.10.2.1.1 US
        • 5.10.2.1.2 Canada
      • 5.10.2.2 Europe
      • 5.10.2.3 Asia Pacific
        • 5.10.2.3.1 Japan
        • 5.10.2.3.2 China
        • 5.10.2.3.3 India
  • 5.11 TRADE ANALYSIS
    • 5.11.1 TRADE ANALYSIS OF NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES (HS CODE 901839)
    • 5.11.2 EXPORT DATA (HS CODE 901839), 2019-2023
    • 5.11.3 IMPORT DATA (HS CODE 901839), 2019-2023
  • 5.12 PATENT ANALYSIS
    • 5.12.1 PATENT PUBLICATION TRENDS FOR PEN NEEDLES
    • 5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.13.2 BUYING CRITERIA
  • 5.14 CASE STUDY ANALYSIS
    • 5.14.1 CASE STUDY 1: IMPACT OF CCG-WIDE INSULIN PEN NEEDLE
    • 5.14.2 CASE STUDY 2: PEN NEEDLE DESIGN INFLUENCES EASE INSERTION, PAIN, AND SKIN TRAUMA IN SUBJECTS WITH TYPE 2 DIABETES
    • 5.14.3 CASE STUDY 3: DROPSAFE SAFETY PEN NEEDLE HELPS TO PREVENT ACCIDENTAL NEEDLESTICKS AFTER INJECTIONS
  • 5.15 TECHNOLOGY ANALYSIS
    • 5.15.1 KEY TECHNOLOGIES
      • 5.15.1.1 Fluid flow enhancement technology
      • 5.15.1.2 Ultra-thin needle technology
    • 5.15.2 COMPLEMENTARY TECHNOLOGIES
      • 5.15.2.1 Microfabricated needles
      • 5.15.2.2 AI in pen injectors
    • 5.15.3 ADJACENT TECHNOLOGIES
      • 5.15.3.1 Autoinjectors
  • 5.16 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.17 ADJACENT MARKET ANALYSIS
    • 5.17.1 AUTOINJECTORS MARKET
    • 5.17.2 INSULIN DELIVERY DEVICES MARKET
    • 5.17.3 INJECTION PENS MARKET
    • 5.17.4 NEEDLES MARKET
  • 5.18 IMPACT OF AI/GEN AI ON PEN NEEDLES MARKET
  • 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESS
  • 5.20 UNMET NEEDS ANALYSIS
  • 5.21 INVESTMENT & FUNDING SCENARIO

6 PEN NEEDLES MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 STANDARD PEN NEEDLES
    • 6.2.1 GREATER PREFERENCE AND AFFORDABILITY OF STANDARD PEN NEEDLES TO SUPPORT GROWTH
  • 6.3 SAFETY PEN NEEDLES
    • 6.3.1 GROWING CONCERNS OVER NEEDLESTICK INJURIES TO DRIVE ADOPTION OF SAFETY PEN NEEDLES

7 PEN NEEDLES MARKET, BY LENGTH

  • 7.1 INTRODUCTION
  • 7.2 8MM
    • 7.2.1 WIDE ADOPTION IN NORTH AMERICA TO BOOST MARKET GROWTH
  • 7.3 5MM
    • 7.3.1 SHORTER LENGTH AND LOW PAIN TO FUEL UPTAKE
  • 7.4 6MM
    • 7.4.1 FAVORABLE REIMBURSEMENTS TO BOOST DEMAND
  • 7.5 4MM
    • 7.5.1 WIDE ADOPTION IN PEDIATRIC INSULIN DELIVERY TO DRIVE DEMAND
  • 7.6 12MM
    • 7.6.1 HIGH UTILIZATION OF SHORTER NEEDLES TO LIMIT ADOPTION
  • 7.7 10MM
    • 7.7.1 PAINFUL PROCEDURES TO RESTRAIN ADOPTION

8 PEN NEEDLES MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 INSULIN THERAPY
    • 8.2.1 RISING INCIDENCE OF DIABETES TO PROPEL MARKET
  • 8.3 GLUCAGON-LIKE PEPTIDE-1 THERAPY
    • 8.3.1 GROWING FOCUS OF PHARMA COMPANIES ON GLP-1 DRUG DEVELOPMENT TO DRIVE MARKET
  • 8.4 GROWTH HORMONE THERAPY
    • 8.4.1 AVAILABILITY OF LONG-ACTING TREATMENTS TO AFFECT DEMAND FOR NEEDLES
  • 8.5 OSTEOPOROSIS
    • 8.5.1 RISING VITAMIN D DEFICIENCY CASES TO PROPEL MARKET
  • 8.6 OTHER APPLICATIONS

9 PEN NEEDLES MARKET, BY MODE OF PURCHASE

  • 9.1 INTRODUCTION
  • 9.2 PRESCRIPTION-BASED PURCHASE
    • 9.2.1 RETAIL PURCHASES TO SUPPORT MARKET GROWTH
  • 9.3 OTC PURCHASES
    • 9.3.1 DISCOUNTS OFFERED BY LOCAL PHARMACIES, SUPPLIERS, AND DISTRIBUTORS TO DRIVE MARKET
  • 9.4 ONLINE PURCHASE
    • 9.4.1 CONVENIENCE AND TIME-EFFICIENT BENEFITS TO PROPEL MARKET
  • 9.5 OTHER MODES OF PURCHASE

10 PEN NEEDLES MARKET, BY CARE SETTING

  • 10.1 INTRODUCTION
  • 10.2 HOME CARE SETTINGS
    • 10.2.1 GROWING PREFERENCE FOR SELF-ADMINISTRATION OF INSULIN TO PROPEL MARKET
  • 10.3 HOSPITALS & CLINICS
    • 10.3.1 INCREASING ADOPTION OF SAFETY PEN NEEDLES TO DRIVE MARKET
  • 10.4 OTHER CARE SETTINGS

11 PEN NEEDLES MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 Increasing burden of diabetes to contribute to growth
    • 11.2.3 CANADA
      • 11.2.3.1 Growing initiatives for diabetic coverage to drive market
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Advanced healthcare system to intensify growth
    • 11.3.3 UK
      • 11.3.3.1 High incidence of cardiovascular disease to favor growth
    • 11.3.4 FRANCE
      • 11.3.4.1 Growing delivery of insulin devices to propel market
    • 11.3.5 ITALY
      • 11.3.5.1 Low product pricing to support growth
    • 11.3.6 SPAIN
      • 11.3.6.1 Supportive regulations mandating the use of safety pen needles to propel market
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 JAPAN
      • 11.4.2.1 Growing inclination toward public health insurance to boost market
    • 11.4.3 CHINA
      • 11.4.3.1 Rising focus on modernizing healthcare to expedite growth
    • 11.4.4 AUSTRALIA & NEW ZEALAND
      • 11.4.4.1 Increasing rate of chronic diseases to amplify growth
    • 11.4.5 INDIA
      • 11.4.5.1 Growing per capita income to fuel market
    • 11.4.6 SOUTH KOREA
      • 11.4.6.1 Increasing geriatric population to facilitate growth
    • 11.4.7 SOUTHEAST ASIA
      • 11.4.7.1 Booming medical tourism industry to drive market
    • 11.4.8 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Growing incidence of non-communicable diseases to drive market
    • 11.5.3 MEXICO
      • 11.5.3.1 Universal health coverage to stimulate growth
    • 11.5.4 ARGENTINA
      • 11.5.4.1 Increasing obesity rates to bolster growth
    • 11.5.5 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO AUGMENT GROWTH
    • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.7 GCC COUNTRIES
    • 11.7.1 HIGHER DISPOSABLE INCOME TO ENCOURAGE GROWTH
    • 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PEN NEEDLES MARKET
  • 12.3 REVENUE ANALYSIS, 2019-2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Region footprint
      • 12.5.5.3 Type footprint
      • 12.5.5.4 Length footprint
      • 12.5.5.5 Application footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING
      • 12.6.5.1 Detailed list of key startups/SMEs
      • 12.6.5.2 Competitive benchmarking of key startups/SMEs
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.8 COMPETITIVE SCENARIO
    • 12.8.1 PRODUCT LAUNCHES & APPROVALS
    • 12.8.2 DEALS
    • 12.8.3 EXPANSIONS
  • 12.9 BRAND/PRODUCT COMPARISON
  • 12.10 R&D EXPENDITURE OF KEY PLAYERS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 EMBECTA CORP.
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Deals
        • 13.1.1.3.2 Expansions
        • 13.1.1.3.3 Other developments
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Right to win
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses & competitive threats
    • 13.1.2 NOVO NORDISK A/S
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Expansions
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Right to win
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses & competitive threats
    • 13.1.3 B. BRAUN SE
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 MnM view
        • 13.1.3.3.1 Right to win
        • 13.1.3.3.2 Strategic choices
        • 13.1.3.3.3 Weaknesses & competitive threats
    • 13.1.4 YPSOMED
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Deals
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Right to win
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses & competitive threats
    • 13.1.5 TERUMO CORPORATION
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 MnM view
        • 13.1.5.3.1 Right to win
        • 13.1.5.3.2 Strategic choices
        • 13.1.5.3.3 Weaknesses & competitive threats
    • 13.1.6 NIPRO
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Expansions
    • 13.1.7 OWEN MUMFORD
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Deals
    • 13.1.8 ARKRAY, INC.
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Expansions
    • 13.1.9 ULTIMED, INC.
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Product launches
    • 13.1.10 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products offered
    • 13.1.11 MONTMED
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products offered
      • 13.1.11.3 Recent developments
        • 13.1.11.3.1 Product approvals
        • 13.1.11.3.2 Deals
    • 13.1.12 HTL-STREFA
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products offered
    • 13.1.13 ALLISON MEDICAL, INC.
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products offered
    • 13.1.14 GLUCORX LIMITED
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products offered
    • 13.1.15 BERPU MEDICAL TECHNOLOGY CO., LTD.
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products offered
  • 13.2 OTHER PLAYERS
    • 13.2.1 VAN HEEK MEDICAL
    • 13.2.2 SIMPLE DIAGNOSTICS
    • 13.2.3 IYON HEALTH MEDICAL
    • 13.2.4 LINKS MEDICAL PRODUCTS INC.
    • 13.2.5 MHC MEDICAL PRODUCTS, LLC
    • 13.2.6 ADVACARE PHARMA
    • 13.2.7 ARTSANA S.P.A.
    • 13.2.8 PROMISEMED MEDICAL DEVICES, INC.
    • 13.2.9 TRIVIDIA HEALTH, INC.
    • 13.2.10 VOGT MEDICAL VERTRIEB GMBH

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 PEN NEEDLES MARKET: STUDY ASSUMPTIONS
  • TABLE 3 PEN NEEDLES MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 4 REIMBURSEMENT OF PEN NEEDLES, BY COUNTRY
  • TABLE 5 INDICATIVE SELLING PRICE OF PEN NEEDLES, BY KEY PLAYER, 2024
  • TABLE 6 PEN NEEDLES MARKET: ROLE IN ECOSYSTEM
  • TABLE 7 PEN NEEDLES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 16 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL
  • TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 18 TRADE ANALYSIS OF NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES, 2023 (USD MILLION)
  • TABLE 19 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES (HS CODE 901839), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 20 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES (HS CODE 901839), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 21 PEN INJECTORS MARKET: MAJOR PATENTS
  • TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES
  • TABLE 23 KEY BUYING CRITERIA FOR PEN NEEDLES
  • TABLE 24 IMPACT OF CCG-WIDE INSULIN PEN NEEDLE
  • TABLE 25 PEN NEEDLE DESIGN INFLUENCES EASE OF INSERTION, PAIN, AND SKIN TRAUMA IN SUBJECTS WITH TYPE 2 DIABETES
  • TABLE 26 DROPSAFE SAFETY PEN NEEDLE HELPS TO PREVENT ACCIDENTAL NEEDLESTICKS AFTER INJECTIONS
  • TABLE 27 PEN NEEDLES MARKET: DETAILED LIST OF CONFERENCES & EVENTS (2025-2026)
  • TABLE 28 PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 29 STANDARD PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 30 STANDARD PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 31 STANDARD PEN NEEDLES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
  • TABLE 32 SAFETY PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 33 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 34 SAFETY PEN NEEDLES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
  • TABLE 35 PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 36 8MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 37 8MM PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 38 5MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 39 5MM PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 40 6MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 41 6MM PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 42 4MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 43 4MM PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 44 12MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 45 12MM PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 46 10MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 47 10MM PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 48 PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 49 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 50 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 51 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 52 PEN NEEDLES MARKET FOR OSTEOPOROSIS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 53 PEN NEEDLES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 54 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 55 PEN NEEDLES MARKET FOR PRESCRIPTION-BASED PURCHASES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 56 PEN NEEDLES MARKET FOR OTC PURCHASES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 57 PEN NEEDLES MARKET FOR ONLINE PURCHASES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 58 PEN NEEDLES MARKET FOR OTHER MODES OF PURCHASE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 59 PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 60 PEN NEEDLES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 61 PEN NEEDLES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 62 PEN NEEDLES MARKET FOR OTHER CARE SETTINGS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 63 PEN NEEDLES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 69 NORTH AMERICA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 70 MACROECONOMIC INDICATORS FOR US
  • TABLE 71 US: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 72 US: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 73 US: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 74 US: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 75 US: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 76 MACROECONOMIC INDICATORS FOR CANADA
  • TABLE 77 CANADA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 78 CANADA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 79 CANADA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 80 CANADA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 81 CANADA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 82 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 83 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 84 EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 85 EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 86 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 87 EUROPE: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 88 MACROECONOMIC INDICATORS FOR GERMANY
  • TABLE 89 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 90 GERMANY: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 91 GERMANY: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 92 GERMANY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 93 GERMANY: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 94 MACROECONOMIC INDICATORS FOR UK
  • TABLE 95 UK: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 96 UK: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 97 UK: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 98 UK: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 99 UK: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 100 MACROECONOMIC INDICATORS FOR FRANCE
  • TABLE 101 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 102 FRANCE: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 103 FRANCE: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 104 FRANCE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 105 FRANCE: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 106 MACROECONOMIC INDICATORS FOR ITALY
  • TABLE 107 ITALY: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 108 ITALY: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 109 ITALY: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 110 ITALY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 111 ITALY: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 112 MACROECONOMIC INDICATORS FOR SPAIN
  • TABLE 113 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 114 SPAIN: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 115 SPAIN: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 116 SPAIN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 117 SPAIN: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 118 REST OF EUROPE: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 119 REST OF EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 120 REST OF EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 121 REST OF EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 122 REST OF EUROPE: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 129 MACROECONOMIC INDICATORS FOR JAPAN
  • TABLE 130 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 131 JAPAN: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 132 JAPAN: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 133 JAPAN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 134 JAPAN: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 135 MACROECONOMIC INDICATORS FOR CHINA
  • TABLE 136 CHINA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 137 CHINA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 138 CHINA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 139 CHINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 140 CHINA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 141 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 142 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 143 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 144 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 145 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 146 MACROECONOMIC INDICATORS FOR INDIA
  • TABLE 147 INDIA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 148 INDIA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 149 INDIA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 150 INDIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 151 INDIA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 152 MACROECONOMIC INDICATORS FOR SOUTH KOREA
  • TABLE 153 SOUTH KOREA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 154 SOUTH KOREA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 155 SOUTH KOREA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 156 SOUTH KOREA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 157 SOUTH KOREA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 158 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 159 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 160 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 161 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 162 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 163 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 164 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 165 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 166 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 167 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 168 LATIN AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 169 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 170 LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 171 LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 172 LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 173 LATIN AMERICA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 174 MACROECONOMIC INDICATORS FOR BRAZIL
  • TABLE 175 BRAZIL: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 176 BRAZIL: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 177 BRAZIL: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 178 BRAZIL: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 179 BRAZIL: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 180 MACROECONOMIC INDICATORS FOR MEXICO
  • TABLE 181 MEXICO: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 182 MEXICO: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 183 MEXICO: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 184 MEXICO: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 185 MEXICO: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 186 MACROECONOMIC INDICATORS FOR ARGENTINA
  • TABLE 187 ARGENTINA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 188 ARGENTINA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 189 ARGENTINA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 190 ARGENTINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 191 ARGENTINA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 192 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 193 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 194 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 195 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 196 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 197 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 198 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 199 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 200 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 201 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 202 GCC COUNTRIES: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 203 GCC COUNTRIES: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 204 GCC COUNTRIES: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 205 GCC COUNTRIES: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 206 GCC COUNTRIES: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 207 PEN NEEDLES MARKET: DEGREE OF COMPETITION
  • TABLE 208 PEN NEEDLES MARKET: REGION FOOTPRINT
  • TABLE 209 PEN NEEDLES MARKET: TYPE FOOTPRINT
  • TABLE 210 PEN NEEDLES MARKET: LENGTH FOOTPRINT
  • TABLE 211 PEN NEEDLES MARKET: APPLICATION FOOTPRINT
  • TABLE 212 PEN NEEDLES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 213 PEN NEEDLES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 214 PEN NEEDLES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021- JANUARY 2025
  • TABLE 215 PEN NEEDLES MARKET: DEALS, JANUARY 2021- JANUARY 2025
  • TABLE 216 PEN NEEDLES MARKET: EXPANSIONS, JANUARY 2021- JANUARY 2025
  • TABLE 217 EMBECTA CORP.: COMPANY OVERVIEW
  • TABLE 218 EMBECTA CORP.: PRODUCTS OFFERED
  • TABLE 219 EMBECTA CORP.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 220 EMBECTA CORP.: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 221 EMBECTA CORP.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 222 NOVO NORDISK A/S: COMPANY OVERVIEW
  • TABLE 223 NOVO NORDISK A/S: PRODUCTS OFFERED
  • TABLE 224 NOVO NORDISK A/S: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 225 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 226 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 227 YPSOMED: COMPANY OVERVIEW
  • TABLE 228 YPSOMED: PRODUCTS OFFERED
  • TABLE 229 YPSOMED: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 230 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 231 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 232 NIPRO: COMPANY OVERVIEW
  • TABLE 233 NIPRO: PRODUCTS OFFERED
  • TABLE 234 NIPRO: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 235 OWEN MUMFORD: COMPANY OVERVIEW
  • TABLE 236 OWEN MUMFORD: PRODUCTS OFFERED
  • TABLE 237 OWEN MUMFORD: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 238 ARKRAY, INC.: COMPANY OVERVIEW
  • TABLE 239 ARKRAY, INC.: PRODUCTS OFFERED
  • TABLE 240 ARKRAY, INC.: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 241 ULTIMED, INC.: COMPANY OVERVIEW
  • TABLE 242 ULTIMED, INC.: PRODUCTS OFFERED
  • TABLE 243 ULTIMED, INC.: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 244 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: COMPANY OVERVIEW
  • TABLE 245 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: PRODUCTS OFFERED
  • TABLE 246 MONTMED: COMPANY OVERVIEW
  • TABLE 247 MONTMED: PRODUCTS OFFERED
  • TABLE 248 MONTMED: PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 249 MONTMED: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 250 HTL-STREFA: COMPANY OVERVIEW
  • TABLE 251 HTL-STREFA: PRODUCTS OFFERED
  • TABLE 252 ALLISON MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 253 ALLISON MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 254 GLUCORX LIMITED: COMPANY OVERVIEW
  • TABLE 255 GLUCORX LIMITED: PRODUCTS OFFERED
  • TABLE 256 BERPU MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 257 BERPU MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
  • TABLE 258 VAN HEEK MEDICAL: COMPANY OVERVIEW
  • TABLE 259 SIMPLE DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 260 IYON HEALTH MEDICAL: COMPANY OVERVIEW
  • TABLE 261 LINKS MEDICAL PRODUCTS INC.: COMPANY OVERVIEW
  • TABLE 262 MHC MEDICAL PRODUCTS, LLC: COMPANY OVERVIEW
  • TABLE 263 ADVACARE PHARMA: COMPANY OVERVIEW
  • TABLE 264 ARTSANA S.P.A.: COMPANY OVERVIEW
  • TABLE 265 PROMISEMED MEDICAL DEVICES, INC.: COMPANY OVERVIEW
  • TABLE 266 TRIVIDIA HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 267 VOGT MEDICAL VERTRIEB GMBH: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MARKETS & REGIONS COVERED
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY CARE SETTING AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: EMBECTA CORP. (2023)
  • FIGURE 9 PEN NEEDLES MARKET: REVENUE ANALYSIS OF TOP FIVE COMPANIES (2023)
  • FIGURE 10 DEMAND-SIDE ANALYSIS
  • FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2030)
  • FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 13 TOP-DOWN APPROACH
  • FIGURE 14 DATA TRIANGULATION METHODOLOGY
  • FIGURE 15 PEN NEEDLES MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 PEN NEEDLES MARKET, BY LENGTH, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 PEN NEEDLES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 18 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 19 PEN NEEDLES MARKET, BY CARE SETTING, 2024 VS. 2030 (USD MILLION)
  • FIGURE 20 GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 21 RISING INCIDENCE OF DIABETES TO PROPEL MARKET
  • FIGURE 22 8MM SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN ASIA PACIFIC IN 2024
  • FIGURE 23 EMERGING MARKETS TO GROW AT HIGHER CAGRS DURING FORECAST PERIOD
  • FIGURE 24 NORTH AMERICA DOMINATED MARKET IN 2024
  • FIGURE 25 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN US, 1995-2030 (MILLION INDIVIDUALS)
  • FIGURE 27 TYPE 1 DIABETIC POPULATION, BY COUNTRY (2022)
  • FIGURE 28 AVERAGE SELLING PRICE TREND OF STANDARD PEN NEEDLES, BY REGION, 2022-2024 (USD)
  • FIGURE 29 PEN NEEDLES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 PEN NEEDLES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 PEN NEEDLES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 32 PEN NEEDLES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 33 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS
  • FIGURE 34 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES
  • FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2014-DECEMBER 2024)
  • FIGURE 36 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PEN NEEDLE PATENTS (JANUARY 2014-DECEMBER 2024)
  • FIGURE 37 TOP APPLICANT COUNTRIES FOR PEN NEEDLE PATENTS (JANUARY 2013-DECEMBER 2024)
  • FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES
  • FIGURE 39 KEY BUYING CRITERIA FOR PEN NEEDLES, BY TYPE
  • FIGURE 40 AUTOINJECTORS MARKET OVERVIEW
  • FIGURE 41 INSULIN DELIVERY DEVICES MARKET OVERVIEW
  • FIGURE 42 INJECTION PENS MARKET OVERVIEW
  • FIGURE 43 NEEDLES MARKET OVERVIEW
  • FIGURE 44 IMPACT OF AI/GEN AI ON PEN NEEDLES MARKET
  • FIGURE 45 PEN NEEDLES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 46 FUNDING AND NUMBER OF DEALS IN PEN NEEDLES MARKET, 2018-2022 (USD MILLION)
  • FIGURE 47 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018-2022
  • FIGURE 48 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018-2022 (USD MILLION)
  • FIGURE 49 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT
  • FIGURE 50 TOTAL FERTILITY RATE IN US POPULATION, 1990-2024
  • FIGURE 51 ASIA PACIFIC: PEN NEEDLES MARKET SNAPSHOT
  • FIGURE 52 PREVALENCE OF DIABETES IN SOUTHEAST ASIA, 2021 VS. 2030
  • FIGURE 53 HEALTHCARE EXPENDITURE IN SOUTHEAST ASIA, 2021 (% GDP)
  • FIGURE 54 ELDERLY POPULATION IN SOUTHEAST ASIA, 2022
  • FIGURE 55 HEALTH EXPENDITURE IN LATIN AMERICA FOR 2021 (% GDP)
  • FIGURE 56 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PEN NEEDLES MARKET
  • FIGURE 57 REVENUE ANALYSIS FOR KEY PLAYERS IN PEN NEEDLES MARKET (2019-2023)
  • FIGURE 58 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PEN NEEDLES MARKET (2023)
  • FIGURE 59 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 60 PEN NEEDLES MARKET: COMPANY FOOTPRINT
  • FIGURE 61 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 62 EV/EBITDA OF KEY VENDORS
  • FIGURE 63 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 64 PEN NEEDLES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 65 PEN NEEDLES MARKET: R&D EXPENDITURE OF KEY PLAYERS (2022 VS. 2023)
  • FIGURE 66 EMBECTA CORP.: COMPANY SNAPSHOT
  • FIGURE 67 NOVO NORDISK A/S: COMPANY SNAPSHOT
  • FIGURE 68 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 69 YPSOMED: COMPANY SNAPSHOT
  • FIGURE 70 TERUMO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 71 NIPRO: COMPANY SNAPSHOT